3732 results for «2025»
3732 results
High-risk left main PCI
21 May 2025 – From EuroPCR 2025
Delve into the complexities of high-risk left main PCI with a focus on procedural planning and managing unexpected challenges such as spontaneous coronary artery dissection. Learn valuable strategies including contingency planning to optimize outcomes in complex interventions.
Management of heavy calcified bifurcation lesions
21 May 2025 – From EuroPCR 2025
This session focuses on the management of heavily calcified bifurcation lesions using advanced techniques such as IVUS guided guidewire recrossing and orbital atherectomy. Learn step-by-step approaches to tackle complex calcific coronary bifurcations and improve procedural success.
My worst PCI complication: how did I treat and could I have prevented it?
21 May 2025 – From EuroPCR 2025
Learn practical strategies to manage life-threatening PCI complications through real case studies. This session highlights techniques and devices employed to overcome complications, preventive measures, and safe outcome optimization during complex interventions.
Tips for challenging TAVI scenarios
21 May 2025 – From EuroPCR 2025
Explore expert tips for navigating challenging TAVI scenarios including cases with stent entrapment, extremely large annuli, and rare anatomical conditions like Klippel Feil syndrome. Understand approaches for intraannular valve prosthesis implantation in complex coronary anatomy.
How to deal with left main culprit in NSTEMI
21 May 2025 – From EuroPCR 2025
This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.
Chronic coronary syndrome with low ejection fraction and left ventricle support
21 May 2025 – From EuroPCR 2025
This session examines the management of chronic coronary syndrome in patients with low ejection fraction, emphasizing the role of left ventricular support. Topics include risks of intracoronary imaging, pharmacological facilitation, mechanical circulatory support, and alternatives like LAVA-ECMO.
Through decisions in complex left main PCI - Isolated ostial left circumflex
21 May 2025 – From EuroPCR 2025
Navigate complex isolated ostial left circumflex lesions with a focus on the integration of imaging and physiological assessment. Learn treatment options and optimisation strategies to improve long-term outcomes in left main PCI through detailed case presentations and expert guidance.
Coronary dissection : when imaging makes the difference
21 May 2025 – From EuroPCR 2025
Explore the critical role of intracoronary imaging in diagnosing and managing coronary dissections and related complications. Through case studies, learn about bailout strategies and the domino effect of decisions during PCI in acute myocardial infarction.
DCB in challenging scenarios - Part 2
20 May 2025 – From EuroPCR 2025
Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...
One year outcomes of transfemoral J-valve for chronic aortic regurgitation, a prospective multicenter study in 127 cases
20 May 2025 – From EuroPCR 2025
In this #europcr 2025 roundtable, Lai Wei and Dongming Hou present the latest data on the transfemoral J-Valve for chronic aortic regurgitation.
They begin with the China-DVD study, highlighting that aortic regurgitation is now slightly more prevalent than aortic stenosis in China. The conversation then shifts to...
Learnings from LANDMARK and Compare-TAVI at 3 years
22 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Andreas Baumbach, Christian Juhl Terkelsen and Didier Tchetche reviewed the latest findings from the LANDMARK and Compare-TAVI 1 trials—both focused on the performance of the Myval balloon-expandable valve.
LANDMARK compared Myval and Myval Octacor to leading self-expanding valves in a randomised controlled trial. At...
Learnings from Evolut Low Risk 5-year and SMART 2-year trials : from evidence to practice
21 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Angela McInerney, Didier Tchétché, and Ole De Backer discuss key results from the SMART and Evolut Low Risk trials. The SMART trial compared balloon-expandable and self-expanding valves in small annulus patients, showing better hemodynamics with the Evolut platform at 2 years. The Evolut...
How to approach succesfully calcified bifurcation lesions?
20 May 2025 – From EuroPCR 2025
Calcified bifurcation lesions remain one of the toughest challenges in interventional cardiology, combining two high-risk features into one complex scenario.
In this EuroPCR 2025 interview, Dejan Milasinovic, Miroslaw Ferenc, and Mohamed Abdel Wahab explain why this subset deserves dedicated attention. They highlight the critical role of intra-coronary...
Tricuspid TEER: learnings from the 2-year outcomes of TRILUMINATE Pivotal trial & bRIGHT study
20 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Marianna Adamo and Ralph Stephan von Bardeleben discussed the latest findings on tricuspid valve repair using transcatheter edge-to-edge repair (TEER).
The 2-year results from the TRILUMINATE Pivotal trial showed a significant reduction in tricuspid regurgitation, lasting improvements in quality of life, and a notable...
Benefits of IVUS plus near-infrared spectroscopy in detecting and managing vulnerable plaques
21 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Nilesh Pareek and Thomas Keeble discuss the clinical value and future potential of NIRS IVUS, a dual-modality imaging system developed by Nipro that combines intravascular ultrasound with near-infrared spectroscopy.
The Makoto™ system and Dualpro™ catheter allow real-time identification of lipid-rich plaques by providing both...
Focal or diffuse coronary disease: how can PPG measurement contribute to clinical decision-making?
22 May 2025 – From EuroPCR 2025
How can physiology guide treatment decisions beyond ischemia detection? In this round-table recorded at EuroPCR 2025, Thomas Engstrøm, Carlos Collet and Jeroen Sonck examine how pullback pressure gradient (PPG) makes it possible to identify the distribution pattern of coronary artery disease—focal or diffuse—based on a continuous...
Duration of DAPT in ACS: The DUAL-ACS Trial
31 Aug 2025
Ali Nazmi Calik interviews David Newby on the landmark DUAL-ACS trial results he presented at ESC Congress 2025 in Madrid.
The trial compared 3 months versus 12 months of dual antiplatelet therapy (DAPT) after myocardial infarction in an all-comer population. Findings suggest that shorter therapy may offer better...
Author
Author
Introducing our recognised EuroPCR Networkers!
How to manage coronary artery disease in TAVI candidates?
20 May 2025 – From EuroPCR 2025
Martine Gilard, Antonio Mangieri, and Marco Barbanti explore the strategy for handling coronary artery disease in patients undergoing TAVI. Is coronary angiography always required beforehand? Should PCI be performed in all cases—and if so, when? This exchange offers key insights to help guide your decisions on...
How to efficiently and safely manage calcified left main disease?
21 May 2025 – From EuroPCR 2025
Nicola Ryan and Flavio Ribichini explore the complexities of calcified left main stem disease, emphasizing the critical role of intracoronary imaging in improving patient outcomes. They discuss the practical use of mechanical circulatory support and debate stenting strategies, offering expert insights on when single or dual...
